Product Pathways - Growth Factors/Cytokines
Human C-C Motif Chemokine 3 (hCCL3/MIP-1-α) #8445
|8445SC||10 µg (With Carrier)||---||In Stock||---|
|8445SF||10 µg (Carrier Free)||---||In Stock||---|
Already purchased this product? Write a Review.
Recombinant human CCL3 (hCCL3) Ala27-Ala92 (Accession #NP_002974) was produced in E. coli at Cell Signaling Technology.
Recombinant hCCL3 does not have a Met on the amino terminus and has a calculated MW of 7445. DTT-reduced and non-reduced protein migrate as 8 kDa polypeptides. The expected amino-terminal ADTPT of recombinant hCCL3 was verified by amino acid sequencing.
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hCCL3. All lots are greater than 98% pure.
The activity of hCCL3 was determined using a THP-1 cell migration assay. The ED50 of each lot is between 0.5-1.2 ng/ml.
The purity of recombinant hCCL3 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hCCL3 and staining overnight with Coomassie Blue.
hCCL3-induced migration of THP-1 cells was asssessd. THP-1 cells were incubated in a 96-well transwell plate with increasing concentrations of hCCL3 in the bottom chamber. After 2 hr, the number of THP-1 cells that migrated to the bottom chamber of the transwell was quantified by measuring DNA content using a fluorescent dye.
Less than 0.01 ng endotoxin/1 μg hCCL3.
With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg hCCL3. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.
CCL3, also know as MIP-1-α, or LD78α, is an 8 kDa member of the C-C family of chemokines, which play key roles in immune surveillance, inflammation, and infection (1). CCL3 shares 68% amino acid identity with CCL4 (MIP-1-β) and 94% amino acid identity with LD78β (1). CCL3 is produced by activated monocytes, activated macrophages, NK cells, and T cells among others (1). There are two receptors for CCL3: CCR1 and CCR5 (1). CCL3 inhibits R5 HIV-1 infection by competing with the virus for its co-receptor, CCR5 (1). CCL3 polymorphisms are associated with risk for the development of rheumatoid arthritis and ulcerative colitis (2,3).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.